AMILI
Singaporean precision gut microbiome firm AMILI raises new funding led by East Ventures
AMILI, a Singapore-based precision gut microbiome company, has on Monday announced that it has secured new funding from venture capital firm East Ventures. The fresh funds will be allocated towards expanding operations into Indonesia with the primary focus on addressing prevalent gut health issues using scientific approaches adapted to the Indonesian…
Cordlife partners AMILI to launch gut microbiome banking service in Southeast Asia
Cordlife Group Limited (Cordlife), a Singapore Exchange mainboard listed consumer healthcare company, and AMILI Pte. Ltd. (AMILI), a Singapore-based microbiome firm, announced Tuesday a strategic partnership to provide the first-ever gut microbiome banking service in Singapore and the region.
Singapore’s AMILI raises $10.5M Series A round led by Vulcan Capital
AMILI, a Singapore-based precision gut microbiome company, said Wednesday it has raised$10.5 million in Series A funding to accelerate its business expansion in Southeast Asia and Greater Asia. The round was led by Vulcan Capital, the investment arm of the late Microsoft Corp co-founder Paul Allen that invests in category-leading technology, internet, and…
